“Moderna released results on Wednesday on an updated coronavirus vaccine targeting the Omicron variant, calling it ‘our lead candidate’ to serve as a booster shot in the fall,” the New York Times reports.
“The firm’s researchers tested a booster dose combining the original vaccine with one targeted specifically against Omicron, the variant that became dominant last winter. They found that the combination produced 1.75 times as much neutralizing antibodies against Omicron as the existing Moderna vaccine did alone.”
Save to Favorites